Magnetic Reflexologic Insoles for Primary Dysmenorrhea
Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Apr 20, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of special magnetic insoles designed for women who experience primary dysmenorrhea, which is a type of menstrual pain. The goal is to see if these insoles can help reduce symptoms like pain, nausea, and dizziness, while also improving the overall quality of life for participants. Women who are interested in joining the trial must have been diagnosed with primary dysmenorrhea, experience moderate to severe pain (rated 3 or higher on a scale), and have regular menstrual cycles.
Participants in this study can expect to use the magnetic insoles easily in their daily lives, and the researchers hope to see improvements in their pain levels and how they feel emotionally. It's important to note that women who are pregnant during the study, those using pain relief medications, or those with pain in other body parts won't be eligible to participate. This study is currently not yet recruiting participants, but it aims to help women find relief from their menstrual pain without relying on traditional medical treatments.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Having been diagnosed with primary dysmenorrhea
- • Visual Analogue Scale (VAS) value is 3 and above
- • The patient has cooperation
- • Having regular menstruation
- Exclusion Criteria:
- • Getting pregnant during treatment
- • Using analgesic medication
- • Visual Analogue Scale (VAS) value should be between 0-3
- • Having pain in another part of the body
About Istanbul Medipol University Hospital
Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Beykoz, Turkey
Patients applied
Trial Officials
Gizem BOZTAŞ ELVERİŞLİ, Ph.D
Study Director
Medipol University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported